ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,147Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 355

$446K Total Retail Price of All Prescriptions

Rank: 97 out of 355

596 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Rhode Island
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

13% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$29 was the average price of a prescription from this provider, compared to $47 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 1,032 949 165 1 1
SIMVASTATIN 757 679 115 2 3
ATORVASTATIN CALCIUM 728 696 124 3 4
OMEPRAZOLE 609 556 111 4 5
ATENOLOL 603 572 95 5 11
PRAVASTATIN SODIUM 596 551 110 6 14
LEVOTHYROXINE SODIUM 596 564 88 6 6
METOPROLOL TARTRATE 532 509 89 8 8
AMLODIPINE BESYLATE 490 450 81 9 2
TRIAMTERENE-HCTZ 408 386 69 10 46
FUROSEMIDE 289 267 50 11 7
METFORMIN HCL 264 250 43 12 12
LOVASTATIN 263 258* 38 13 27
ALPRAZOLAM 260 237 55 B 14 21
METOPROLOL SUCCINATE 257 218 41 15 20
WARFARIN SODIUM 244 239* 24 16 10
ALENDRONATE SODIUM 243 231 38 17 23
METFORMIN HCL ER 237 223 43 18 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 224 205 42 19 38
PAROXETINE HCL 218 213* 31 20 52
SERTRALINE HCL 217 205 32 21 15
HYDROCHLOROTHIAZIDE 217 195 35 21 9
ALLOPURINOL 206 201* 29 23 29
CRESTOR 184 165 37 24 34
GABAPENTIN 176 171* 45 25 19
LOSARTAN POTASSIUM 174 169* 26 26 13
TRAZODONE HCL 163 139 25 27 16
TAMSULOSIN HCL 160 155* 25 28 26
LOSARTAN-HYDROCHLOROTHIAZIDE 147 136 24 29 55
FLUOXETINE HCL 134 129* 22 30 59
CITALOPRAM HBR 124 108 23 31 18
FENOFIBRATE* 122 117* 16 32 58
GLIPIZIDE ER 114 109* 24 33 72
GLYBURIDE-METFORMIN HCL 110 105* 23 R 34 146
PREDNISONE 104 99* 74 35 41
LORAZEPAM 103 98* 17 B 36 30
GLIPIZIDE 93 93 13 37 47
BENAZEPRIL HCL 93 70 12 37 120
VERAPAMIL ER 91 79 12 39 83
BISOPROLOL-HYDROCHLOROTHIAZIDE 87 <11 <11 40 91
CLOPIDOGREL 85 74 14 41 22
ENALAPRIL MALEATE 84 84 13 42 49
QUINAPRIL HCL 79 <11 <11 43 63
VENLAFAXINE HCL ER 79 53 12 43 78
NIFEDIPINE ER 77 <11 <11 45 117
AZITHROMYCIN 75 70* 65 46 64
GLIPIZIDE XL 70 <11 <11 47 115
PANTOPRAZOLE SODIUM 66 61* 15 48 33
CLONAZEPAM 64 45 11 B 49 39
DONEPEZIL HCL 64 <11 <11 49 24
SYNTHROID 59 <11 <11 51 43
ESCITALOPRAM OXALATE 59 59 12 51 51
CYMBALTA 58 58 11 53 44
LOVAZA 58 <11 <11 53 209
FLUTICASONE PROPIONATE 58 46 18 53 35
DILTIAZEM 24HR ER 58 <11 <11 53 70
ETODOLAC 54 49* 27 57 337
NEXIUM 53 <11 <11 58 60
MONTELUKAST SODIUM 51 <11 <11 59 56
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.